Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Porphyrias, Hepatic”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Large-scale testing (Phase 3)Study completedNCT01605136
What this trial is testing

Phase III Confirmatory Study in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 93
Testing effectiveness (Phase 2)Study completedNCT02949830
What this trial is testing

Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria
Alnylam Pharmaceuticals 16
Early research (Phase 1)Study completedNCT02943213
What this trial is testing

Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride

Who this might be right for
Anti-PsychoticManagement of Manifestations of Psychotic DisordersTreatment of Schizophrenia+6 more
Cycle Pharmaceuticals Ltd. 20
Large-scale testing (Phase 3)Study completedNCT04053270
What this trial is testing

Multicentre Phase III Erythropoietic Protoporphyria Study

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 100
Testing effectiveness (Phase 2)Study completedNCT06971900
What this trial is testing

GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)
Portal Therapeutics, Inc. 28
Large-scale testing (Phase 3)Active Not RecruitingNCT06910358
What this trial is testing

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc 183
Early research (Phase 1)Study completedNCT02082860
What this trial is testing

Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria

Who this might be right for
Acute Intermittent Porphyria
Digna Biotech S.L. 8
Not applicableStudy completedNCT03682731
What this trial is testing

Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Bispebjerg Hospital 14
Not applicableUnknownNCT00206869
What this trial is testing

Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Bispebjerg Hospital
Not applicableStudy completedNCT00213772
What this trial is testing

Risk Factors of Porphyria Cutanea Tarda (PCT)

Who this might be right for
Porphyria Cutanea Tarda
University Hospital, Strasbourg, France 280
Not applicableLooking for participantsNCT01561157
What this trial is testing

Longitudinal Study of the Porphyrias

Who this might be right for
Acute PorphyriasCutaneous Porphyrias
The American Porphyrias Expert Collaborative 1,500
Large-scale testing (Phase 3)Study completedNCT00418795
What this trial is testing

Porphozym in the Treatment of Acute Attacks in AIP

Who this might be right for
Acute Intermittent Porphyria
Zymenex A/S 36
Testing effectiveness (Phase 2)UnknownNCT01284946
What this trial is testing

Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
Assistance Publique - Hôpitaux de Paris 45
Testing effectiveness (Phase 2)Study completedNCT03520036
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria (EPP)
Tanabe Pharma America, Inc. 102
Large-scale testing (Phase 3)Study completedNCT00979745
What this trial is testing

Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 74
Testing effectiveness (Phase 2)Study completedNCT05020184
What this trial is testing

Effect of Oral Cimetidine in the Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaX-linked Protoporphyria
Amy K. Dickey, M.D. 26
Not applicableStudy completedNCT01880983
What this trial is testing

Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))

Who this might be right for
Erythropoietic Protoporphyria (EPP)
University of Alabama at Birmingham 150
Not applicableStudy completedNCT01568554
What this trial is testing

Clinical Diagnosis of Acute Porphyria

Who this might be right for
Hereditary Coproporphyria (HCP)Acute Intermittent Porphyria (AIP)Variegate Porphyria (VP)
University of California, San Francisco 148
Large-scale testing (Phase 3)Looking for participantsNCT07820085
What this trial is testing

Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)EPP2
Portal Therapeutics, Inc. 225
Testing effectiveness (Phase 2)Study completedNCT01573754
What this trial is testing

Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
The University of Texas Medical Branch, Galveston 48
Next Page